MDGL FY 2015 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MDGLMadrigal Pharmaceuticals, Inc.

$10B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$7M

EPS (Diluted)

$-401.56

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$72M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$68M

Total Liabilities

$18M

Stockholders' Equity

$50M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$673,000	+100.0%
Operating Income	-$3M	-$84M	+96.2%
Net Income	-$7M	-$86M	+92.1%